申请人:CADILA HEALTHCARE LTD
                            
                            
                                公开号:WO2013054351A1
                            
                            
                                公开(公告)日:2013-04-18
                            
                            The present invention relates to novel pyrimidine class of compounds, their pharmaceutically acceptable salts, and pharmaceutically acceptable compositions containing them and their use in medicine.
                            本发明涉及新型
嘧啶类化合物,其药用盐和药用组合物,以及包含它们的药用用途。